Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism
Jim C. Hu, Stephen B. Williams, A. James O'Malley, Matthew R. Smith, Paul L. Nguyen, Nancy L. Keating
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism'. Together they form a unique fingerprint.